MedPath

To evaluate in Human volunteers bioequivalence of Flutisone Cream (Fluticasone propionate BP 0.05% w/w)with Reference Listed Drug Flutivate Skin Cream (Fluticasone propionate IP 0.05% w/w) , by comparison of vaso constriction caused.

Phase 4
Completed
Registration Number
CTRI/2012/08/002881
Lead Sponsor
Apex Laboratories Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Subjects should be responders to the drug (have demonstrated blanching response to RLD Flutivate Skin Cream )

-Phototype III and IV.

-Age: 18-45 years.

-Has been fully informed and willing to sign Informed Consent Document.

-Non-tobacco-using subjects.

-Presenting normal healthy skin type

-Cooperating, informed of the need and duration of the examinations.

-For which the investigator considers that the compliance will be correct.

-Healthy Subjects (Healthy/ Good health as demonstrated by lack of clinically significant abnormalities in medical history and clinical assessment, as judged by the Investigator).

Exclusion Criteria

-Clinically significant hypertension or circulatory disease.

-Chronic illness which may influence the skin sensitivity.

-History of allergy to any cosmetic product/ topical application.

-Subject in an exclusion period or participating in another cosmetic or therapeutic trial.

-Presence of any skin condition or pigmentation that would interfere with the placement of test sites or the response or assessment of skin blanching.

-Subjects on any medical treatment either systemic or topical presently or in the past 1 month).

-Drug or alcohol addiction requiring treatment (in-patient or out-patient) in the 12 months prior to dosing.

-Any obvious difference in skin color between arms.

-Use of any vasoactive (constrictor or dilator) medication, prescription or OTC, that could modulate blood flow.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath